Oncology

Merck Serono’s work in oncology focuses on identifying key molecules involved in the formation of cancer, which can then be used in the development of novel targeted treatments that specifically attack cancer cells. This targeted approach improves efficacy and may also reduce the incidence of certain adverse events seen with many currently available therapies. Research activities are focused on three areas:

• Compounds that act directly on tumor cells
• Compounds that act indirectly on tumor cells via their interaction with their local environment
• Compounds that enhance the immune system

Merck Serono’s range of development compounds comprises both chemically and biologically active ingredients. Using this targeted approach, Merck Serono aims to prolong the survival of cancer patients and increase their quality of life. Altogether, there are eight projects in Phase I, seven projects in Phase II and four projects in Phase III.

For more information about cancer click on the Cancer Association of South Africa (CANSA)  web link here www.cansa.org.za

Or visit the National Cancer Institute of the USA here www.cancer.gov